Unknown

Dataset Information

0

Early hepatic insulin resistance precedes the onset of diabetes in obese C57BLKS-db/db mice.


ABSTRACT:

Objective

To identify metabolic derangements contributing to diabetes susceptibility in the leptin receptor-deficient obese C57BLKS/J-db/db (BKS-db) mouse strain.

Research design and methods

Young BKS-db mice were used to identify metabolic pathways contributing to the development of diabetes. Using the diabetes-resistant B6-db strain as a comparison, in vivo and in vitro approaches were applied to identify metabolic and molecular differences between the two strains.

Results

Despite higher plasma insulin levels, BKS-db mice exhibit lower lipogenic gene expression, rate of lipogenesis, hepatic triglyceride and glycogen content, and impaired insulin suppression of gluconeogenic genes. Hepatic insulin receptor substrate (IRS)-1 and IRS-2 expression and insulin-stimulated Akt-phosphorylation are decreased in BKS-db primary hepatocytes. Hyperinsulinemic-euglycemic clamp studies indicate that in contrast to hepatic insulin resistance, skeletal muscle is more insulin sensitive in BKS-db than in B6-db mice. We also demonstrate that elevated plasma triglyceride levels in BKS-db mice are associated with reduced triglyceride clearance due to lower lipase activities.

Conclusions

Our study demonstrates the presence of metabolic derangements in BKS-db before the onset of beta-cell failure and identifies early hepatic insulin resistance as a component of the BKS-db phenotype. We propose that defects in hepatic insulin signaling contribute to the development of diabetes in the BKS-db mouse strain.

SUBMITTER: Davis RC 

PROVIDER: S-EPMC2889760 | biostudies-literature | 2010 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Objective</h4>To identify metabolic derangements contributing to diabetes susceptibility in the leptin receptor-deficient obese C57BLKS/J-db/db (BKS-db) mouse strain.<h4>Research design and methods</h4>Young BKS-db mice were used to identify metabolic pathways contributing to the development of diabetes. Using the diabetes-resistant B6-db strain as a comparison, in vivo and in vitro approaches were applied to identify metabolic and molecular differences between the two strains.<h4>Results</h  ...[more]

Similar Datasets

| S-EPMC4623289 | biostudies-literature
| S-EPMC4290036 | biostudies-literature
| S-EPMC6911300 | biostudies-literature
| S-EPMC2840808 | biostudies-other
| S-EPMC4370469 | biostudies-literature
| S-EPMC5056960 | biostudies-literature
| S-EPMC3577828 | biostudies-literature
| S-EPMC2844847 | biostudies-literature
| S-EPMC4239088 | biostudies-literature
| S-EPMC2451047 | biostudies-other